FR3113237B1 - Produit pour le traitement de maladies virales par voie nasale - Google Patents
Produit pour le traitement de maladies virales par voie nasale Download PDFInfo
- Publication number
- FR3113237B1 FR3113237B1 FR2008276A FR2008276A FR3113237B1 FR 3113237 B1 FR3113237 B1 FR 3113237B1 FR 2008276 A FR2008276 A FR 2008276A FR 2008276 A FR2008276 A FR 2008276A FR 3113237 B1 FR3113237 B1 FR 3113237B1
- Authority
- FR
- France
- Prior art keywords
- product
- treatment
- viral diseases
- nasal
- way
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Otolaryngology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Botany (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
PRODUIT POUR LE TRAITEMENT DE MALADIES VIRALES PAR VOIE NASALE L’invention concerne un produit pour le traitement par voie nasale de maladies virales, comme le COVID-19. Le produit comprend un hydrogel comprenant du glycérol, un carbomère, et éventuellement un mucopolysaccharide.
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR2008276A FR3113237B1 (fr) | 2020-08-04 | 2020-08-04 | Produit pour le traitement de maladies virales par voie nasale |
FR2010995A FR3113249B1 (fr) | 2020-08-04 | 2020-10-27 | Produit pour le traitement par voie nasale de maladies virales |
CA3188053A CA3188053A1 (fr) | 2020-08-04 | 2021-08-03 | Hydrogel comprenant du glycerol et un carbomere pour le traitement par voie nasale des symptomes respiratoires de la maladie covid-19 |
PCT/EP2021/071696 WO2022029140A1 (fr) | 2020-08-04 | 2021-08-03 | Hydrogel comprenant du glycerol et un carbomere pour le traitement par voie nasale des symptomes respiratoires de la maladie covid-19 |
CN202180067905.9A CN116249515A (zh) | 2020-08-04 | 2021-08-03 | 用于通过鼻腔途径治疗covid-19疾病的呼吸道症状的包含甘油和卡波姆的水凝胶 |
EP21755445.0A EP4192424A1 (fr) | 2020-08-04 | 2021-08-03 | Hydrogel comprenant du glycerol et un carbomere pour le traitement par voie nasale des symptomes respiratoires de la maladie covid-19 |
US18/040,468 US20230330013A1 (en) | 2020-08-04 | 2021-08-03 | Hydrogel comprising glycerol and a carbomer for treating the respiratory symptoms of covid-19 disease via the nasal route |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR2008276A FR3113237B1 (fr) | 2020-08-04 | 2020-08-04 | Produit pour le traitement de maladies virales par voie nasale |
FR2008276 | 2020-08-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR3113237A1 FR3113237A1 (fr) | 2022-02-11 |
FR3113237B1 true FR3113237B1 (fr) | 2023-06-09 |
Family
ID=73038196
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR2008276A Active FR3113237B1 (fr) | 2020-08-04 | 2020-08-04 | Produit pour le traitement de maladies virales par voie nasale |
FR2010995A Active FR3113249B1 (fr) | 2020-08-04 | 2020-10-27 | Produit pour le traitement par voie nasale de maladies virales |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR2010995A Active FR3113249B1 (fr) | 2020-08-04 | 2020-10-27 | Produit pour le traitement par voie nasale de maladies virales |
Country Status (1)
Country | Link |
---|---|
FR (2) | FR3113237B1 (fr) |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6080783A (en) * | 1998-09-01 | 2000-06-27 | Gum Tech International, Inc. | Method and composition for delivering zinc to the nasal membrane |
FR2973701B1 (fr) * | 2011-04-06 | 2013-10-04 | Biopass S A | Composition pour application topique |
DK3370692T3 (da) | 2015-07-14 | 2023-06-26 | Marinomed Biotech Ag | Sammensætning til frigørelse af tilstoppet næse med antiviral aktivitet |
CN106511321B (zh) * | 2016-12-20 | 2019-03-29 | 四川省中医药科学院 | 具有抗炎/抗病毒作用的组合物及药物 |
CN110840826A (zh) * | 2019-11-19 | 2020-02-28 | 长春呈实健康实业有限公司 | 一种鼻阻隔剂及其制备方法 |
CN111437270A (zh) * | 2020-04-24 | 2020-07-24 | 瑞希(重庆)生物科技有限公司 | 一种卡拉胶鼻用即型凝胶喷雾剂及其制备方法 |
CN111544556A (zh) * | 2020-05-07 | 2020-08-18 | 中国人民解放军军事科学院军事医学研究院 | 一种适用于病毒性感冒、病毒性肺炎的中药组合物及其给药方式和制备 |
CN111773150A (zh) * | 2020-06-22 | 2020-10-16 | 复旦大学 | 一种抗covid-19免洗手凝胶及其制备方法 |
-
2020
- 2020-08-04 FR FR2008276A patent/FR3113237B1/fr active Active
- 2020-10-27 FR FR2010995A patent/FR3113249B1/fr active Active
Also Published As
Publication number | Publication date |
---|---|
FR3113249B1 (fr) | 2024-01-19 |
FR3113249A1 (fr) | 2022-02-11 |
FR3113237A1 (fr) | 2022-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR20210387A (es) | Inhibidores de kif18a | |
MX2022001181A (es) | Inhibidores de kif18a. | |
MX2021007157A (es) | Heteroarilamidas utiles como inhibidores de kif18a. | |
MX2021007158A (es) | Heteroarilamidas utiles como inhibidores de kif18a. | |
HN2005000508A (es) | Procesos para la preparacion de 2-(2,6-dixopiperidin-3-il)-1-oxoisoindolinas sustituidas | |
EA202190006A1 (ru) | Пуриноновые соединения и их применение при лечении рака | |
EA201071413A1 (ru) | Способ и композиция для лечения повышения внутриглазного давления и глаукомы | |
EA202290054A1 (ru) | Полиспецифические антитела, содержащие только тяжелые цепи, которые связываются с cd22 и cd3 | |
CR20220626A (es) | Compuestos para el tratamiento de enfermedades y trastornos asociados a braf | |
EA201790889A1 (ru) | Офтальмологический раствор | |
MA53268B1 (fr) | Mini-gde pour le traitement de maladies de stockage de glycogène de type iii | |
MA55872A (fr) | Anticorps anti-sema3a et leurs utilisations pour le traitement de maladies oculaires | |
MX2021002380A (es) | Conjugados de isoquinolina-esteroide y usos de los mismos. | |
MX2022013650A (es) | Imidazopirimidinas como moduladores de il-17. | |
MA37709A1 (fr) | Pansement a liberation prolongee d'actifs | |
MX2023004869A (es) | Anticuerpos contra sars-cov-2 y usos de los mismos. | |
ZA202107428B (en) | Porcine circovirus type 3 (pcv3) vaccines, and production and uses thereof | |
MX2021011576A (es) | Nuevos compuestos y composiciones farmaceuticas de los mismos para el tratamiento de trastornos inflamatorios. | |
MX2022001084A (es) | Metodo de tratamiento de la enfermedad de alzheimer mediante la regulacion de microrganismos intestinales. | |
FR3113237B1 (fr) | Produit pour le traitement de maladies virales par voie nasale | |
MX2023012672A (es) | Nuevo anticuerpo anti-vista estable. | |
EP4169925A3 (fr) | Procédé pour la préparation de dérivés de tétrahydrothiénopyridine n-substitués et leurs utilisations | |
PH12017500998A1 (en) | Treatment of ocular conditions using progenitor cells | |
BR112022011950A2 (pt) | Tratamento da nefropatia membranosa, doença relacionada ao igg4, e síndrome antifosfolipídica usando o inibidor btk 2-[(3r)-3-[4-4-amino-3-(2-fluoro-4-4-fenoxi-fenil)pirazolo[3], 4-4-d]pyrimidin-1-yl]piperidina-1-carbonil]-4-4-metil-4-4-[4-4-(oxetan-3-yl)piperazin-1-il]pent-2-enenitrila | |
WO2020214100A3 (fr) | Composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 2 |
|
PLSC | Publication of the preliminary search report |
Effective date: 20220211 |
|
PLFP | Fee payment |
Year of fee payment: 3 |
|
RM | Correction of a material error |
Effective date: 20221104 |
|
TP | Transmission of property |
Owner name: COSMOSOFT, FR Effective date: 20221206 |
|
PLFP | Fee payment |
Year of fee payment: 4 |